Bhaskar Anand, SVP, Chief Accounting Officer at REATA PHARMACEUTICALS INC (RETA), sold 403 shares at $168.42 ($68K) on 2023-08-16, disclosed to the SEC on 2023-08-17.
Open-market sale of $68k RETA by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.06 | 193 | $33K | 48.0% |
| 2 | $168.42 | 210 | $35K | 52.0% |
| Total | $168.73 avg | 403 | $68K | 100% |
| Filing → |
| RETA | SELL | 2023-05-17 | $93K | — | Filing → |
| RETA | SELL | 2023-03-08 | $14K | — | Filing → |
| RETA | SELL | 2023-03-06 | $143K | — | Filing → |